Related Experiment Video
Updated: Oct 17, 2025
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.3K
The cure of leukemia through the optimist's prism
Hagop M Kantarjian1, Nitin Jain1, Guillermo Garcia-Manero1
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer
|October 6, 2021
Summary
Recent advancements offer potential cures for various leukemias. Novel therapies like targeted inhibitors and antibody treatments significantly improve survival rates for acute myeloid leukemia, chronic myeloid leukemia, and others.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Significant progress has been made in leukemia treatment since 2018.
- Numerous discoveries have improved therapies and outcomes for specific leukemia subsets.
Purpose of the Study:
- To review recent advancements in leukemia therapy.
- To highlight improved treatment outcomes and survival rates across various leukemia types.
Main Methods:
- Review of recent therapeutic discoveries and clinical outcomes.
- Analysis of novel drug regimens including targeted therapies, antibody treatments, and chemotherapy combinations.
Main Results:
- Hairy cell leukemia: potentially curable with cladribine and rituximab (≥90% 10-year survival).
- Acute promyelocytic leukemia: 80-90% cure rate with all-trans retinoic acid and arsenic trioxide.
- Chronic myeloid leukemia: survival near normal population with BCR-ABL1 tyrosine kinase inhibitors (TKIs).
- Chronic lymphocytic leukemia: potentially curable with Bruton tyrosine kinase inhibitors and venetoclax.
- Philadelphia chromosome-positive acute lymphoblastic leukemia: >70% 5-year survival with chemotherapy and ponatinib; newer regimens show outstanding results.
- Acute myeloid leukemia (AML) and myelodysplastic syndrome: improved outcomes with venetoclax, FLT3/IDH inhibitors, and oral hypomethylating agents.
Conclusions:
- Leukemia treatment has seen rapid, transformative progress.
- Novel targeted therapies and antibody-based treatments are revolutionizing leukemia care, offering potential cures and significantly improved survival rates for many subsets.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
01:22Bone Marrow Sampling and Transplants
568
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
568
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:49Cancer Therapies
8.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.2K
01:26Curing Methods
135
Concrete members with a small surface-to-volume ratio are cured by oiling and moistening the forms before casting the concrete member. These forms can be left in place for a prolonged period to prevent moisture loss, and can be wetted if made of a material suitable for wetting. If the forms are removed early, the concrete member is moistened and covered with polythene sheets to maintain moisture. For large horizontal concrete surfaces exposed to dry weather, a temporary covering is suspended...
135
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K